EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge

Bang Li, Xiang-Rong Qin, Jia-Chen Qu, Guan-du Wu, Wen-Kang Zhang, Ze-Zheng Jiang, Pan-Pan Liu, Ze-Min Li, Tian-Mei Yu, Chuan-Min Zhou, Yong-Jun Jiao, Xue-Jie Yu iD

PLOS Pathogens · 2025

DOI: 10.1371/journal.ppat.1012889 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, 2025. Verfasst von Bang Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Virology, School of Public Health, Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Phlebovirus, Antibodies, Neutralizing, Antibodies, Viral. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shandong Province of China, Nanjing Important Science & Technology Specific Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe fever with thrombocytopenia syndrome (SFTS) is a viral hemorrhagic fever caused by a tick-borne virus SFTSV with a mortality rate of up to 30%. Currently, there is no vaccine or effective therapy for SFTS. Neutralizing monoclonal antibody therapy, which provides immediate passive immunity and may limit disease progression, has emerged as a reliable approach for developing therapeutic drugs for SFTS. In this study, 4 human monoclonal antibodies (hmAbs) derived from convalescent SFTS patients’ lymphocytes based on human single-chain variable fragment antibody libraries were tested for their neutralizing activities in cells and their treatment effect in animals individually and in pair combinations. The neutralization test showed that all 4 hmAbs exhibited strong neutralizing activity against SFTSV infection in vitro . The protection rate of hmAbs 4-6, 1F6, 1B2, and 4-5 against SFTSV lethal challenge in IFNAR1 -/- A129 mice are 50%, 16.7%, 83.3%, and 66.7%, respectively. Notably, the pair combination of antibodies (1B2 and 4-5, 1B2 and 1F6) that recognized distinct epitopes protected 100% of mice against SFTSV lethal challenge. In conclusion, our findings indicate that the pair combinations of hmAbs 1B2 and 4-5 or hmAbs 1B2 and 1F6 may serve as promising therapeutic drugs for treating SFTSV infection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalPhlebovirusAntibodies, NeutralizingAntibodies, ViralSevere Fever with Thrombocytopenia SyndromeBunyaviridae InfectionsAnimalsMiceHumansImmunization, PassiveFemaleMice, KnockoutNeutralization Tests

Substanzen

Antibodies, MonoclonalAntibodies, NeutralizingAntibodies, Viral

Autor:innen und Institutionen

  • State Key Laboratory of Virology, School of Public Health, Wuhan University, Wuhan, China.
  • Department of Clinical Laboratory, The Second Hospital of Shandong University, Jinan, China.
  • Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Institute of Pathogenic Microbiology, Jiangsu Provincial Center for Disease Prevention and Control, Nanjing, China.

ORCID-Profile: Xue-Jie Yu

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province of China
  • Nanjing Important Science & Technology Specific Projects
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Li, B., Qin, X. R., Qu, J. C., Wu, G. D., Zhang, W. K., Jiang, Z. Z., Liu, P. P., Li, Z. M., Yu, T. M., Zhou, C. M., Jiao, Y. J., & Yu, X. J. (2025). Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge. PLOS Pathogens. https://doi.org/10.1371/journal.ppat.1012889

Vancouver

Li B, Qin XR, Qu JC, Wu GD, Zhang WK, Jiang ZZ, et al. Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge. PLOS Pathogens. 2025. doi:10.1371/journal.ppat.1012889

BibTeX
@article{Li2025,
  author = {Li, Bang and Qin, Xiang-Rong and Qu, Jia-Chen and Wu, Guan-du and Zhang, Wen-Kang and Jiang, Ze-Zheng and Liu, Pan-Pan and Li, Ze-Min and Yu, Tian-Mei and Zhou, Chuan-Min and Jiao, Yong-Jun and Yu, Xue-Jie},
  title = {Pair combinations of human monoclonal antibodies fully protected mice against bunyavirus SFTSV lethal challenge},
  journal = {PLOS Pathogens},
  year = {2025},
  doi = {10.1371/journal.ppat.1012889}
}
Kostenlos starten →